Immunicum AB (publ): Interim Report Q3 - Corporate Update and Outlook

What we doOur approachPipelineTechnologyPublications
About usExecutive ManagementBoard of DirectorsScientific Advisory Board
News & eventsPress releasesEventsInterviews
Investors
Careers

Back
Immunicum AB (publ): Interim Report Q3 - Corporate Update and Outlook
 8:00:36 AM

Keep reading
Immunicum AB (publ) Presents Further Preclinical Ilixadencel Mode of Action Data at Annual SITC MeetingRead